RA0007

antibody from Oursmab

Targeting: ADM AM

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0007

Provider

Oursmab

Product name

Enibarcimab (Biosimilar Reference Antibody) (ADM)

Antibody type

Monoclonal

Description

Enibarcimab (development code Adrecizumab) is an investigational, humanized monoclonal antibody developed for the treatment of acute and critical conditions involving vascular dysfunction. It functions as a neutralizing agent against the peptide hormone Adrenomedullin (ADM). Specifically, it is designed to bind and neutralize the bioactive, free form of ADM in the bloodstream, while not interfering with its precursor or bound forms. This targeted neutralization is believed to protect the vascular endothelial barrier, reduce excessive vasodilation, and help maintain vascular integrity during severe systemic stress, thereby counteracting pathological processes associated with circulatory shock and organ dysfunction.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.